ZYMENEX ApS: Financial statements 2018
CVR: 27394752
ZYMENEX ApS (CVR 27394752) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 10,758,000 and a net result of DKK 1,292,000 compared with DKK 3,404,000 the year before. That is a decrease of 72.8% compared with the year before. The profit margin was 12%. Equity amounted to DKK 82,550,000. The solvency ratio was 51.6%.
- Revenue
- 10,758,000 kr.
- Gross Profit
- 10,758,000 kr.
- Profit/Loss
- 1,292,000 kr.
- Equity
- 82,550,000 kr.
- Total Assets
- 160,123,000 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 10.8 mio. | 10.8 mio. | 1.3 mio. | 82.5 mio. | - |
| 2017 | 39.6 mio. | 39.6 mio. | 3.4 mio. | 80.9 mio. | - |
| 2016 | 49.1 mio. | 49.1 mio. | 294.4 mio. | 230.3 mio. | - |
| 2015 | - | -52.5 mio. | 656 t. | -64.1 mio. | - |
| 2014 | - | -67.9 mio. | 1.1 mio. | -64.8 mio. | - |
Keep an eye on ZYMENEX ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
ZYMENEX ApS has published its annual report for 2017. Revenue came to DKK 39,575,000, and the net result was DKK 3,404,000.
About ZYMENEX ApS
ZYMENEX ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2003 and dissolved in 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 1 employee. In 2018, the company reported revenue of DKK 10,758,000 and a net result of DKK 1,292,000 compared with DKK 3,404,000 the year before. Equity amounted to DKK 82,550,000.
